X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32555) 32555
Newsletter (3849) 3849
Publication (1804) 1804
Book Review (401) 401
Magazine Article (178) 178
Book Chapter (91) 91
Book / eBook (87) 87
Newspaper Article (61) 61
Conference Proceeding (46) 46
Web Resource (38) 38
Trade Publication Article (36) 36
Dissertation (20) 20
Journal / eJournal (8) 8
Paper (7) 7
Reference (5) 5
Data Set (2) 2
Streaming Video (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26770) 26770
thrombolytic therapy (21635) 21635
male (14340) 14340
female (13417) 13417
middle aged (11351) 11351
aged (10486) 10486
index medicus (8397) 8397
treatment outcome (7096) 7096
cardiac & cardiovascular systems (6306) 6306
thrombolytic drugs (5995) 5995
thrombolytic therapy - methods (5887) 5887
myocardial infarction - drug therapy (5446) 5446
adult (5397) 5397
fibrinolytic agents - therapeutic use (5299) 5299
stroke (5058) 5058
time factors (4940) 4940
thrombolysis (4911) 4911
peripheral vascular disease (4811) 4811
tissue plasminogen activator - therapeutic use (4305) 4305
clinical neurology (3989) 3989
myocardial infarction - therapy (3963) 3963
risk factors (3803) 3803
aged, 80 and over (3797) 3797
care and treatment (3522) 3522
research (3242) 3242
stroke - drug therapy (3171) 3171
retrospective studies (3042) 3042
mortality (2999) 2999
therapy (2983) 2983
thrombolytic therapy - adverse effects (2781) 2781
medicine, general & internal (2766) 2766
acute myocardial-infarction (2758) 2758
fibrinolytic agents - administration & dosage (2728) 2728
prognosis (2673) 2673
myocardial infarction - mortality (2574) 2574
heart attack (2566) 2566
acute disease (2500) 2500
electrocardiography (2465) 2465
tissue plasminogen activator - administration & dosage (2375) 2375
thrombosis (2350) 2350
myocardial infarction (2301) 2301
prospective studies (2254) 2254
acute ischemic-stroke (2250) 2250
angioplasty, balloon, coronary (2225) 2225
surgery (2224) 2224
trial (2065) 2065
follow-up studies (2047) 2047
animals (2041) 2041
tissue-plasminogen activator (2040) 2040
management (2030) 2030
drug therapy (2011) 2011
myocardial infarction - physiopathology (1935) 1935
angioplasty (1884) 1884
tissue plasminogen activator (1871) 1871
reports (1834) 1834
anticoagulants - therapeutic use (1832) 1832
reperfusion (1815) 1815
ischemia (1787) 1787
myocardial infarction - diagnosis (1719) 1719
drugs (1714) 1714
brain ischemia - drug therapy (1687) 1687
stroke - therapy (1684) 1684
coronary angiography (1650) 1650
universities and colleges (1636) 1636
streptokinase - therapeutic use (1619) 1619
hematology (1610) 1610
streptokinase (1580) 1580
analysis (1546) 1546
fibrinolytic agents - adverse effects (1537) 1537
health aspects (1519) 1519
fibrinolysis (1491) 1491
neurosciences (1476) 1476
tomography, x-ray computed (1443) 1443
cardiology (1424) 1424
heart attacks (1410) 1410
recurrence (1410) 1410
medical research (1383) 1383
thrombosis - drug therapy (1371) 1371
radiology, nuclear medicine & medical imaging (1355) 1355
alteplase (1345) 1345
stents (1325) 1325
stroke - diagnosis (1266) 1266
anticoagulants (1262) 1262
pulmonary embolism (1243) 1243
combined modality therapy (1224) 1224
cardiac patients (1221) 1221
urokinase-type plasminogen activator - therapeutic use (1207) 1207
tissue plasminogen activator - adverse effects (1206) 1206
heparin - therapeutic use (1193) 1193
acute myocardial infarction (1191) 1191
randomized controlled trials as topic (1187) 1187
myocardial infarction - complications (1181) 1181
medicine, experimental (1177) 1177
abridged index medicus (1176) 1176
risk (1163) 1163
usage (1160) 1160
diagnosis (1128) 1128
tissue-plasminogen-activator (1126) 1126
medicine & public health (1117) 1117
infusions, intravenous (1108) 1108
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (55) 55
Online Resources - Online (31) 31
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Gerstein Science - Periodical Stacks (2) 2
Scarborough Hospital - General (2) 2
Toronto East General Hospital - Stacks (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32139) 32139
German (1230) 1230
French (601) 601
Spanish (560) 560
Japanese (405) 405
Italian (372) 372
Russian (359) 359
Chinese (236) 236
Portuguese (150) 150
Polish (142) 142
Norwegian (101) 101
Danish (96) 96
Swedish (86) 86
Czech (83) 83
Turkish (65) 65
Dutch (63) 63
Hungarian (62) 62
Korean (30) 30
Finnish (26) 26
Hebrew (23) 23
Serbian (20) 20
Croatian (18) 18
Slovak (17) 17
Icelandic (9) 9
Lithuanian (6) 6
Romanian (6) 6
Ukrainian (5) 5
Persian (3) 3
Slovenian (3) 3
Bulgarian (2) 2
Arabic (1) 1
Bosnian (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e669S - e690S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e1S - e23S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e576S - e600S
Background: Antithrombotic therapy in valvular disease is important to mitigate thromboembolism, but the hemorrhagic risk imposed must be considered. Methods:... 
RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Heart Valve Diseases - blood | Mitral Valve | Thrombosis - complications | Ductus Arteriosus, Patent - drug therapy | Humans | Postoperative Complications - blood | Postoperative Complications - prevention & control | Stroke - complications | Hemorrhage - prevention & control | Rheumatic Heart Disease - blood | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Ductus Arteriosus, Patent - blood | Thromboembolism - prevention & control | Aspirin - adverse effects | Heart Valve Diseases - complications | Fibrinolytic Agents - therapeutic use | Rheumatic Heart Disease - drug therapy | Rheumatic Heart Disease - complications | Aspirin - therapeutic use | Thromboembolism - drug therapy | Postoperative Complications - drug therapy | Thrombosis - blood | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Catheterization | Heart Atria | Heart Valve Prosthesis | Risk Factors | Ductus Arteriosus, Patent - complications | Combined Modality Therapy | Evidence-Based Medicine | Stroke - blood | Thromboembolism - blood | Heart Valve Diseases - drug therapy | Thrombosis - drug therapy | Hemorrhage - chemically induced | Thrombolytic Therapy - adverse effects | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e601S - e636S
Objectives: This article provides recommendations on the use of antithrombotic therapy in patients with stroke or transient ischemic attack (TIA). Methods: We... 
HIGH-RISK PATIENTS | TISSUE-PLASMINOGEN ACTIVATOR | CEREBRAL VENOUS THROMBOSIS | PATENT FORAMEN OVALE | RESPIRATORY SYSTEM | LONG-TERM SURVIVAL | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | ASPIRIN PLUS DIPYRIDAMOLE | NONVALVULAR ATRIAL-FIBRILLATION | EXTENDED-RELEASE DIPYRIDAMOLE | CRITICAL CARE MEDICINE | Recombinant Proteins - therapeutic use | United States | Humans | Heparin - therapeutic use | Tissue Plasminogen Activator - therapeutic use | Intracranial Thrombosis - prevention & control | Recombinant Proteins - adverse effects | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ischemic Attack, Transient - etiology | Aspirin - therapeutic use | Intracranial Thrombosis - drug therapy | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Intermittent Pneumatic Compression Devices | Intracranial Thrombosis - blood | Combined Modality Therapy | Stroke - drug therapy | Evidence-Based Medicine | Stroke - blood | Intracranial Thrombosis - etiology | Thrombolytic Therapy | Ischemic Attack, Transient - blood | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Book
1990, ISBN 0702014745, Volume 3/no. 3., x, p. 483-836.
Book
American Heart Journal, ISSN 0002-8703, 2011, Volume 161, Issue 5, pp. 815 - 821.e6
Journal Article
Circulation, ISSN 0009-7322, 08/2013, Volume 128, Issue 9, pp. 962 - 969
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 2001, Volume 357, Issue 9272, pp. 1905 - 1914
Journal Article
Journal Article
Stroke, ISSN 0039-2499, 01/2009, Volume 40, Issue 1, pp. 140 - 146
Background and Purpose-While intravenous recombinant tissue plasminogen activator (rt-PA) has been approved for acute stroke therapy within 3 hours, the... 
Vertrobrobasilary disease | Abciximab | Acute stroke | Emergency medicine | Neurocritial care | Stents | Thrombolysis | Antiplatelet agents | Interventional neuroradiology | INTRAVENOUS ABCIXIMAB | antiplatelet agents | MULTICENTER | emergency medicine | THROMBOSIS | stents | RECANALIZATION | interventional neuroradiology | vertrobrobasilary disease | CLINICAL NEUROLOGY | TRIAL | FIBRINOLYSIS | CHOICE | INFARCTION | acute stroke | neurocritial care | abciximab | DISEASE | thrombolysis | PERIPHERAL VASCULAR DISEASE | ISCHEMIC-STROKE | Infusions, Intra-Arterial - statistics & numerical data | Outcome Assessment (Health Care) - methods | Infusions, Intra-Arterial - standards | Prospective Studies | Recovery of Function - drug effects | Humans | Middle Aged | Male | Young Adult | Vertebrobasilar Insufficiency - drug therapy | Vertebrobasilar Insufficiency - mortality | Platelet Aggregation Inhibitors - administration & dosage | Thrombolytic Therapy - methods | Aged, 80 and over | Recovery of Function - physiology | Adult | Female | Thrombolytic Therapy - standards | Infusions, Intra-Arterial - methods | Basilar Artery - drug effects | Vertebrobasilar Insufficiency - pathology | Thrombolytic Therapy - statistics & numerical data | Survival Rate | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Radiography | Diagnostic Imaging | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Basilar Artery - pathology | Injections, Intravenous - methods | Aged | Basilar Artery - diagnostic imaging | Fibrinolytic Agents - administration & dosage | Injections, Intravenous - standards | Injections, Intravenous - statistics & numerical data
Journal Article
2007, 1st ed., ISBN 0470319380, xiv, 350 p., [4] p. of plates
Intravascular thrombus formation remains one of the most significant problems in cardiovascular medicine. It underlies the clinical presentation of acute... 
Thrombosis -- Treatment | Fibrinolytic agents | Thrombolytic therapy | Cardiovascular Disease | Medical / Cardiology | Treatment | Thrombosis
Book
Journal Article